CH534156A - Verfahren zur Herstellung von a-(Halogenphenoxy--isobutyryl)-B-nicotinoyl-glykolen - Google Patents

Verfahren zur Herstellung von a-(Halogenphenoxy--isobutyryl)-B-nicotinoyl-glykolen

Info

Publication number
CH534156A
CH534156A CH1094770A CH1094770A CH534156A CH 534156 A CH534156 A CH 534156A CH 1094770 A CH1094770 A CH 1094770A CH 1094770 A CH1094770 A CH 1094770A CH 534156 A CH534156 A CH 534156A
Authority
CH
Switzerland
Prior art keywords
halophenoxy
nicotinoyl
isobutyryl
glycols
preparation
Prior art date
Application number
CH1094770A
Other languages
English (en)
Inventor
Nat Scherm Arthur Dr Rer
Dezsoe Dr Peteri
Original Assignee
Merz & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE1941217A external-priority patent/DE1941217C3/de
Application filed by Merz & Co filed Critical Merz & Co
Publication of CH534156A publication Critical patent/CH534156A/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B67—OPENING, CLOSING OR CLEANING BOTTLES, JARS OR SIMILAR CONTAINERS; LIQUID HANDLING
    • B67B—APPLYING CLOSURE MEMBERS TO BOTTLES JARS, OR SIMILAR CONTAINERS; OPENING CLOSED CONTAINERS
    • B67B1/00—Closing bottles, jars or similar containers by applying stoppers
    • B67B1/08—Securing stoppers, e.g. swing stoppers, which are held in position by associated pressure-applying means coacting with the bottle neck

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • Medicinal Chemistry (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH1094770A 1969-08-13 1970-07-17 Verfahren zur Herstellung von a-(Halogenphenoxy--isobutyryl)-B-nicotinoyl-glykolen CH534156A (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE1941217A DE1941217C3 (de) 1969-08-13 1969-08-13 Alpha- eckige Klamer auf 2-(p-Chlorphenoxy)-isobutyryril eckige Klammer zu-beta-nicotinoylglykolester und Verfahren zu seiner Herstellung

Publications (1)

Publication Number Publication Date
CH534156A true CH534156A (de) 1973-02-28

Family

ID=5742695

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1094770A CH534156A (de) 1969-08-13 1970-07-17 Verfahren zur Herstellung von a-(Halogenphenoxy--isobutyryl)-B-nicotinoyl-glykolen

Country Status (6)

Country Link
US (1) US3723446A (de)
AT (1) AT296986B (de)
BE (1) BE753639A (de)
CH (1) CH534156A (de)
ES (1) ES382339A1 (de)
FR (1) FR2068494B1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2270878B1 (de) * 1974-05-15 1978-02-03 Fabre Sa Pierre
US4051143A (en) * 1974-09-05 1977-09-27 Merz & Co. Process for the production of α-[2-(p-chlorophenoxy)-isobutyryl]-β-nicotinoyl glycol ester
BE826867A (fr) * 1974-11-20 1975-07-16 Medicament hypolipidemiant et hydrocholesterolemiant
ES438246A1 (es) * 1975-06-04 1977-01-16 Alter Sa Un procedimiento de preparacion del glicol 2-(p-clorofenoci)-2-metilpropinato nicotinato.
US6083497A (en) * 1997-11-05 2000-07-04 Geltex Pharmaceuticals, Inc. Method for treating hypercholesterolemia with unsubstituted polydiallylamine polymers
NZ543741A (en) * 2003-05-30 2009-10-30 Ranbaxy Lab Ltd Substituted pyrrole derivatives and their use as HMG-Co inhibitors
US8026377B2 (en) * 2005-11-08 2011-09-27 Ranbaxy Laboratories, Limited Process for (3R, 5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-[(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid hemi calcium salt
AR059838A1 (es) * 2006-03-14 2008-04-30 Ranbaxy Lab Ltd Formulaciones para dosis estabilizantes de estatina
WO2008010087A2 (en) * 2006-07-14 2008-01-24 Ranbaxy Laboratories Limited Polymorphic forms of an hmg-coa reductase inhibitor and uses thereof
CN101555224B (zh) * 2009-04-15 2012-01-18 大道隆达（北京）医药科技发展有限公司 一种依托贝特的制备方法
DK3253382T3 (da) 2015-02-06 2022-02-14 Intercept Pharmaceuticals Inc Farmaceutiske sammensætninger til kombinationsterapi
JP2022536060A (ja) 2019-05-30 2022-08-12 インターセプト ファーマシューティカルズ， インコーポレイテッド 胆汁鬱滞性肝疾患の処置で使用するためのｆｘｒアゴニストおよびフィブラートを含む医薬組成物

Also Published As

Publication number Publication date
AT296986B (de) 1972-03-10
FR2068494A1 (de) 1971-08-27
ES382339A1 (es) 1973-07-01
FR2068494B1 (de) 1974-08-30
BE753639A (de) 1970-12-31
US3723446A (en) 1973-03-27

Similar Documents

Publication Publication Date Title
AT298508B (de) Verfahren zur Herstellung von Mercaptoalkylalkoxysilanen
AT302277B (de) Verfahren zur Herstellung von Chinondiiminen
CH526566A (de) Verfahren zur Herstellung von 5-Pyridyl-2-imidazolonen
CH508604A (de) Verfahren zur Herstellung von Ureidophenylguanidinen
CH534156A (de) Verfahren zur Herstellung von a-(Halogenphenoxy--isobutyryl)-B-nicotinoyl-glykolen
AT304774B (de) Verfahren zur Herstellung von 16β-Methyl-9α-fluor-steroiden
CH525881A (de) Verfahren zur Herstellung von 4-Alkylprolinen
CH505041A (de) Verfahren zur Herstellung von Cycloalkenonen
CH531480A (de) Verfahren zur Herstellung von Aminoadamantanen
CH541557A (de) Verfahren zur Herstellung von a-(Hydroxy- und -Alkoxy- substituierten)-phenyl-a-(2-piperidinyl)-methanolen
AT319485B (de) Verfahren zur Herstellung von 19-Norsteroiden
AT296961B (de) Verfahren zur Herstellung von Alkyldihydroxybenzolen
CH511225A (de) Verfahren zur Herstellung von Amidophenylthioharnstoffen
CH529108A (de) Verfahren zur Herstellung von y-Cyanbutyraldiminen
CH523903A (de) Verfahren zur Herstellung von substituierten 3-Amino-benzothiophenen
CH538469A (de) Verfahren zur Herstellung von substituierten Tetralonen
AT308086B (de) Verfahren zur Herstellung von 1-Alkoxyanthrachinonen
CH530408A (de) Verfahren zur Herstellung von Chinolylpiperazinen
AT305503B (de) Verfahren zur herstellung von neuem 9alpha-fluor-16-fluormethylen-prednisolon-21-oenanthat
AT299905B (de) Verfahren zur Herstellung von β-Acetoxypivalinaldehyd
AT296297B (de) Verfahren zur Herstellung von N-Tritylimidazolen und -triazolen
CH530358A (de) Verfahren zur Herstellung von 2-Methyl-4-halogen-but-2-en-1-alen
AT299251B (de) Verfahren zur Herstellung von Organo-H-chlorsilanen
AT294833B (de) Verfahren zur Herstellung von N-Tritylimidazolen und -triazolen
AT296298B (de) Verfahren zur Herstellung von N-Tritylimidazolen und -triazolen

Legal Events

Date Code Title Description
PL Patent ceased